Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia: A Multicenter, Randomized, Placebo-Controlled Trial

NCT06610760 is registered in ClinicalTrials.gov with Yongquan Shi as lead sponsor.

NCT NCT06610760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06610760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia: A Multicenter, Randomized, Placebo-Controlled Trial
Lead sponsor
Yongquan Shi
Phase
Phase 4
Overall status
Recruiting
Start date
November 12, 2024
Completion date
October 31, 2026
Enrollment
196 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gastric intestinal metaplasia